Clinical Value of the MRI Combined With SCC-Ag for the Diagnosis of HSIL (CIN 2/3)

CompletedOBSERVATIONAL

Enrollment

186

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

December 1, 2022

Study Completion Date

December 31, 2022

Conditions

Magnetic Resonance Imaging Examination

Interventions

DIAGNOSTIC_TEST

MRI,SCC-Ag

Magnetic Resonance Imaging examination,serum squamous cells carcinoma antigen

Trial Locations (1)

The 2nd Affiliated Hospital and Yuying Children's Hospital of WMU, Wenzhou

All Listed Sponsors

lead

Second Affiliated Hospital of Wenzhou Medical University

OTHER

NCT05487209 - Clinical Value of the MRI Combined With SCC-Ag for the Diagnosis of HSIL (CIN 2/3) | Biotech Hunter | Biotech Hunter